Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 18;7(1):9.
doi: 10.1186/s40795-021-00410-w.

Nutritional perspectives on sickle cell disease in Africa: a systematic review

Eunice Berko Nartey  1   2 , Jonathan Spector  3 , Seth Adu-Afarwuah  4 , Catherine L Jones  5 , Alan Jackson  6 , Agartha Ohemeng  4 , Rajiv Shah  7 , Alice Koryo-Dabrah  8 , Amma Benneh-Akwasi Kuma  9 , Hyacinth I Hyacinth  10   11 , Matilda Steiner-Asiedu  4
Affiliations

Nutritional perspectives on sickle cell disease in Africa: a systematic review

Eunice Berko Nartey et al. BMC Nutr. .

Abstract

Background: Sickle cell disease (SCD) is an inherited blood disorder that predominantly affects individuals in sub-Saharan Africa. However, research that elucidates links between SCD pathophysiology and nutritional status in African patients is lacking. This systematic review aimed to assess the landscape of studies in sub-Saharan Africa that focused on nutritional aspects of SCD, and highlights gaps in knowledge that could inform priority-setting for future research.

Methods: The study was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Inclusion criteria comprised original, peer-reviewed research published between January 1995 and November 2020 involving individuals in Africa with any phenotypic variant of SCD and at least one nutritional status outcome. Nutritional status outcomes were defined as those that assessed dietary intakes, growth/anthropometry, or nutritional biomarkers. Databases used were Ovid Embase, Medline, Biosis and Web of Science.

Results: The search returned 526 articles, of which 76 were included in the final analyses. Most investigations (67%) were conducted in Nigeria. Studies were categorized into one of three main categories: descriptive studies of anthropometric characteristics (49%), descriptive studies of macro- or micronutrient status (41%), and interventional studies (11%). Findings consistently included growth impairment, especially among children and adolescents from sub-Saharan Africa. Studies assessing macro- and micronutrients generally had small sample sizes and were exploratory in nature. Only four randomized trials were identified, which measured the impact of lime juice, long-chain fatty acids supplementation, ready-to-use supplementary food (RUSF), and oral arginine on health outcomes.

Conclusions: The findings reveal a moderate number of descriptive studies, most with small sample sizes, that focused on various aspects of nutrition and SCD in African patients. There was a stark dearth of interventional studies that could be used to inform evidence-based changes in clinical practice. Findings from the investigations were generally consistent with data from other regional settings, describing a significant risk of growth faltering and malnutrition among individuals with SCD. There is an unmet need for clinical research to better understand the potential benefits of nutrition-related interventions for patients with SCD in sub-Saharan Africa to promote optimal growth and improve health outcomes.

Keywords: Malnutrition; Nutritional status; Sickle cell anemia; Sickle cell disease; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Rajiv Shah is an employee of Novartis Global Health and Corporate Responsibility. Jonathan Spector is an employee at the Novartis Institute for Tropical Diseases. Catherine Jones was an employee at the Novartis Institute for Tropical Diseases at the time she contributed to this manuscript.

Figures

Fig. 1
Fig. 1
Literature search flowchart
See this image and copyright information in PMC

References

    1. Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017;390:311–323. doi: 10.1016/S0140-6736(17)30193-9. - DOI - PubMed
    1. Pauling L, Itano H. Sickle cell anemia a molecular disease. Science (80- ) 1949;110:543–548. doi: 10.1126/science.110.2865.543. - DOI - PubMed
    1. Ingram VM. Abnormal human haemoglobins. I. the comparison of normal human and sickle-cell haemoglobins by fingerprinting. Biochim Biophys Acta. 1958;28:539–545. doi: 10.1016/0006-3002(58)90516-x. - DOI - PubMed
    1. Bunn H, Forget B. Hemoglobin: molecular, genetic and clinical aspects. Philadelphia, PA, USA: WB Saunders; 1986.
    1. Mbanya N. Sickle cell disease in subsaharan Africa. Vox Sang. 2015;109:63–64.

LinkOut - more resources